[22] [23] 4 mg (TA875) and tirzepatide for weight management, which set out the eligibility criteria for these licensed medicines
Maintain adequate hydration (1.52 litres daily), eat small frequent meals, take Rybelsus correctly on an empty stomach, monitor blood glucose regularly, rise slowly from sitting or lying positions, and avoid alcohol
Drugs such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda, Victoza) are transforming how we approach metabolic health
Phase 3 TRIUMPH trials are ongoing, with results expected throughout 2026
Hims seems to think it has found some sort of precedent some of Mikes Secret Stuff to work around existing patent protections and continue to grow the obesity segment in the event the shortage ends
GLP-1 receptor agonists versus Metformin in PCOS: a systematic review and meta-analysis